Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells
- PMID: 15915542
- DOI: 10.1002/eji.200526066
Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells
Abstract
Dendritic cells (DC) are key components of innate and adaptive immune responses. Plasmacytoid DC (PDC) are a specialized DC subset that produce high amounts of type I interferons in response to microbes. High mobility group box 1 protein (HMGB1) is an abundant nuclear protein, which acts as a potent pro-inflammatory factor when released extracellularly. We show that HMGB1 leaves the nucleus of maturing PDC following TLR9 activation, and that PDC express on the plasma membrane the best-characterized receptor for HMGB1, RAGE. Maturation and type I IFN secretion of PDC is hindered when the HMGB1/RAGE pathway is disrupted. These results reveal HMGB1 and RAGE as the first known autocrine loop modulating the maturation of PDC, and suggest that antagonists of HMGB1/RAGE might have therapeutic potential for the treatment of systemic human diseases.
Similar articles
-
The secretion of HMGB1 is required for the migration of maturing dendritic cells.J Leukoc Biol. 2007 Jan;81(1):84-91. doi: 10.1189/jlb.0306171. Epub 2006 Oct 11. J Leukoc Biol. 2007. PMID: 17035340
-
Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.Mol Immunol. 2005 Feb;42(4):433-44. doi: 10.1016/j.molimm.2004.07.023. Mol Immunol. 2005. PMID: 15607795
-
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Angiogenesis. 2008. PMID: 18264787 Review.
-
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.Immunol Rev. 2007 Dec;220:35-46. doi: 10.1111/j.1600-065X.2007.00574.x. Immunol Rev. 2007. PMID: 17979838 Review.
-
The role of HMGB1/RAGE in inflammatory cardiomyopathy.Semin Thromb Hemost. 2010 Mar;36(2):185-94. doi: 10.1055/s-0030-1251503. Epub 2010 Apr 22. Semin Thromb Hemost. 2010. PMID: 20414834 Review.
Cited by
-
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.Sci Rep. 2023 Nov 9;13(1):19440. doi: 10.1038/s41598-023-46254-1. Sci Rep. 2023. PMID: 37945630 Free PMC article.
-
Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress.Cancers (Basel). 2023 Feb 23;15(5):1404. doi: 10.3390/cancers15051404. Cancers (Basel). 2023. PMID: 36900196 Free PMC article. Review.
-
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases.Front Immunol. 2022 Oct 6;13:1008047. doi: 10.3389/fimmu.2022.1008047. eCollection 2022. Front Immunol. 2022. PMID: 36275647 Free PMC article. Review.
-
Plasmacytoid Dendritic Cells Mediate Myocardial Ischemia/Reperfusion Injury by Secreting Type I Interferons.J Am Heart Assoc. 2021 Aug 3;10(15):e020754. doi: 10.1161/JAHA.121.020754. Epub 2021 Jul 30. J Am Heart Assoc. 2021. PMID: 34325534 Free PMC article.
-
NLRP3 inflammasome activation contributes to development of alopecia areata in C3H/HeJ mice.Exp Dermatol. 2022 Feb;31(2):133-142. doi: 10.1111/exd.14432. Epub 2021 Jul 26. Exp Dermatol. 2022. PMID: 34270818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
